Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

—Clinicians may be underestimating the cognitive burden on patients with MS, underscoring the need for more comprehensive cognitive assessments and assessing patient-reported outcomes. A growing body ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Lipoic acid offers no improvements in walking speed or other outcomes in patients with progressive multiple sclerosis ...

The FDA rejected Sanofi's MS drug tolebrutinib, citing liver injury risks, unclear benefits, and trial data that failed to ...

Resistance training is effective for improving gait speed in individuals with multiple sclerosis. The intensity and duration of resistance training are important factors in determining the magnitude ...

Fear of relapse and worsening disease is common for MS patients, leading to poorer mental health, per a study calling for ...

NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...

Cold weather can significantly worsen multiple sclerosis symptoms, triggering stiffness, fatigue, and reduced mobility.

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...